Impression Healthcare Limited announced that it has received the relevant licenses from the Department of Health, Victoria to sell or supply, by wholesale, scheduled cannabinoid substances. Specifically, the licenses includes; Cannabis, Cannabidiol (CBD), Tetrahydrocannabinols (THC) and Dronabinol. IHL has made arrangements with 3rd party suppliers where necessary to facilitate secure product handling and distribution as per the necessary processes for patient distribution of scheduled cannabinoid medicines. Having the licenses in place facilitates all aspects of Impression's medicinal cannabis activities, including: Sales of cannabinoid medicines throughout Australia, where the law permits, under the Special Access Scheme and through the Authorised Prescriber Network. Import and Export of cannabinoid medicines to and from Australia.